Duck Tembusu virus detection kit and its application
By using yeast-expressed NS1 protein and chemiluminescence ELISA technology in the Yatanbusu virus detection kit, the specificity and sensitivity of the existing detection methods are solved, and the early accurate detection of Yatanbusu virus is achieved. and distinguish, improving detection accuracy and efficiency.
Patent Information
- Application Number
- CN202410165127.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-02-05
- Publication Date
- 2024-11-22
- Estimated Expiration
- 2044-02-05
AI Technical Summary
The existing detection methods for Yatanbusu virus are not specific and sensitive, and are prone to false positive and false negative results. It is difficult to distinguish between antibodies produced by natural infection and inactivated vaccines, affecting the accuracy of the detection.
Using NS1 protein as the coated antigen of the detection kit, recombinant NS1 protein was obtained through the yeast expression system, combined with chemiluminescent ELISA technology, a high accuracy, sensitivity and specific Yatanbusu virus detection kit can be developed, which can be used in Accurately detect viruses in the early stages of infection and distinguish between antibodies produced by natural infection and inactivated vaccine immunization.
Early detection and accurate identification of Yatanbusu virus was achieved, the occurrence of false positive and false negative results was reduced, the accuracy and efficiency of the detection were improved, and it had important prevention and control significance.
Smart Images

Figure BDA0004699496580000111 
Figure BDA0004699496580000121 
Figure BDA0004699496580000131
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of biological detection, and in particular to a duck Tembusu virus detection kit and application thereof. Background Art
[0002] Duck Tembusu virus disease is an infectious disease caused by duck Tembusu virus (DTMUV), characterized by a sharp drop in egg production, growth retardation, and ovarian hemorrhage, causing significant losses to the breeding industry. DTMUV is widespread and can be found in waterfowl breeding areas. In addition, it can occur all year round, which is very harmful and hinders the healthy and vigorous development of the duck breeding industry. The mature virus particles of DTMUV are spherical in appearance, with a diameter of mostly 45-55nm. The surface has a lipid envelope composed of M protein, with spikes composed of E protein on it. The viral RNA contained in the center is wrapped in the envelope by icosahedral symmetrical nucleocapsid protein.
[0003] At present, the isolation and identification of viruses is used as the basis for diagnosis. It is necessary to collect the severely lesioned parts of the diseased animals under sterile conditions and inoculate them into SPF avian embryos to isolate the pathogens. This method has the advantage of high specificity and can be directly used as the basis for diagnosis, but this method is time-consuming, costly, and requires high operator requirements.
[0004] RT-PCR is to extract RNA from diseased tissues, reverse transcribe it according to gene-specific primers, produce cDNA, amplify it with TAq enzyme and NDV-specific primers, and detect the amplified products with agarose gel electrophoresis. The advantages of this method are high specificity and sensitivity, simple and fast operation, and direct diagnosis. The disadvantage is that it has high requirements for the experimental environment and is only suitable for laboratory diagnosis. The agar diffusion experiment is to inject soluble antigens and antibodies into the agar gel, and move from the sample well to the center through free diffusion. When the soluble antigen and the antibody that can specifically bind to it meet in a suitable ratio, a single white precipitation line visible to the naked eye can appear, which is a positive reaction. However, the results of this method are affected by many factors, the sensitivity is not high, and the probability of false positive results is high. Colloidal gold immunochromatography technology uses colloidal gold to mark the monoclonal antibody of a protein of the pathogen to be tested. The obtained immune colloidal gold solution is covered on the gold label pad to capture the specific antigen in the sample to be tested. This method is simple and has a fast detection speed, but it is prone to false positives and has poor specificity. The principle of enzyme-linked immunosorbent assay (ELISA) is to physically absorb antibodies or antigens onto a solid phase carrier and then perform immunoenzyme assay. Since this method has the advantages of simple operation, fast detection speed and strong specificity, it has been widely used in the detection and diagnosis of most animal infectious diseases. There are commercial ELISA kits on the market for detecting antibody types, but the coated antigens are highly conservative between different flaviviruses, so different flaviviruses cannot be distinguished and identified. In addition, in the early stages of animal infection, the level of neutralizing antibodies produced in the body is low, and the disease cannot be detected in time, which may lead to the omission of some infected animals. With the emergence of more and more vaccines, it is difficult to distinguish whether the antibodies produced in the body are naturally infected or produced by inactivated vaccines, and the ordinary ELISA detection method has low detection sensitivity and is prone to false negatives.
[0005] In view of this, the present invention is proposed. Summary of the invention
[0006] In view of the technical problems existing in the background technology, the present invention provides a duck Tembusu virus detection kit and application.
[0007] Specifically, the technical solution provided by the present invention is as follows:
[0008] In a first aspect, the present invention provides the use of NS1 protein in preparing a duck Tembusu virus detection kit, wherein the NS1 protein is obtained by gene expression of the nucleotide sequence shown in SEQ ID NO.1.
[0009] NS1 protein is the main antigen in the process of virus infection, which can induce the body to produce high levels of antibodies. The present invention uses NS1 protein as the coating antigen in the duck Tembusu virus detection kit, and utilizes the main production time of NS1 protein (NS1 protein is produced when the virus infects cells), so as to distinguish antibodies produced by natural infection and inactivated vaccine immunization. At the same time, NS1 protein can be detected in the early stage of duck Tembusu virus infection, indicating that NS1 protein is related to the early infection of the virus, and NS1 protein can be used to accurately detect duck Tembusu virus disease in the early stage of infection.
[0010] Preferably, the duck Tembusu virus detection kit of the present invention is a chemiluminescent ELISA antibody detection kit, comprising a coating solution, wherein the coating solution uses a carbonate buffer with a pH value of 9.2-9.8 as a base solvent, and the added antigen is 0.09-0.11 μg / ml NS1 protein.
[0011] More preferably, the coating solution uses carbonate buffer with a pH value of 9.6 as the base solvent, and the added antigen is 0.1 μg / ml NS1 protein. The 0.1 μg / ml antigen coating concentration has the best effect on the light index and signal-to-noise ratio in subsequent optical detection.
[0012] The application of the NS1 protein provided by the present invention in the chemiluminescent ELISA antibody detection kit has the advantages of high accuracy, high sensitivity, strong specificity, high efficiency, etc., and is of great significance for preventing and controlling the occurrence and prevalence of duck Tembusu disease.
[0013] Preferably, the NS1 protein is obtained by expressing the gene of the nucleotide sequence shown in SEQ ID NO.1 through a yeast expression system, and the yeast expression system is obtained by transforming the PmeI linearized positive recombinant expression plasmid into Pichia pastoris X-33 by electroporation.
[0014] In a more specific embodiment provided by the present invention, the steps of obtaining the NS1 protein are:
[0015] According to the gene sequence of duck Tembusu virus NS1 protein published in GenBank, the primers for NS1 protein gene were designed and synthesized. The gene sequence cDNA of duck Tembusu virus NS1 protein was used as a template to PCR amplify the NS1 fragment and connect it with the pMD18-T-simple vector to construct a recombinant cloning plasmid, which was transformed into Escherichia coli DH5α. The positive clones were screened by bacterial liquid PCR, double enzyme digestion and gene sequencing. Then, the positive recombinant cloning plasmid and expression vector pPICZαC were double digested with restriction endonucleases to recover the target gene. DNA ligase was used to connect and construct a recombinant expression plasmid, which was transformed into Escherichia coli DH5α. The positive recombinant expression plasmid was screened by bacterial liquid PCR, double enzyme digestion and gene sequencing, and the expression plasmid was constructed. The positive recombinant expression plasmid was linearized with PmeⅠ and transformed into Pichia pastoris X-33 by electroporation. Positive recombinants were screened for induced expression, and the recombinant protein was identified by SDS-PAGE analysis and Western-blot. The biological activity of the purified recombinant protein was detected by duck Tembusu virus enzyme-linked immunosorbent assay. The protein was used to coat chemiluminescent plates to detect duck Tembusu virus antibody-positive serum and duck Tembusu virus antibody-negative serum. The results showed that the expressed NS1 protein had good sensitivity and specificity.
[0016] The purified recombinant protein was used to immunize female SALB / c mice aged 6-8 weeks, and a shock immunization was performed after three immunizations. The spleen cells of the immunized mice were fused with myeloma cells SP2 / 0, and three subclones were performed. The positive hybridoma cell lines were screened by indirect ELISA, the cells were expanded and cultured, and ascites was prepared. The collected ascites was purified and labeled with HRP enzyme to obtain enzyme-labeled monoclonal antibodies. The expressed NS1 protein was subjected to SDS-PAGE electrophoresis and then transferred to a nitrocellulose membrane, and reacted with the enzyme-labeled monoclonal antibody, and specific protein bands appeared. This shows that the monoclonal antibody prepared by the present invention has good specificity.
[0017] The NS1 protein with a nucleotide sequence as shown in SEQ ID NO.1 provided by the present invention has a better antigen immune effect obtained by a yeast expression system. At the same time, the yeast expression system is simpler and more convenient, with low cost, and the secretory expression product is easy to purify. The recombinant NS1 protein can be correctly folded and glycosylated, has the biological activity that a natural protein should have, and can improve the protein expression efficiency.
[0018] In a second aspect, the present invention provides a detection kit, comprising a coating solution, wherein the coating solution uses a carbonate buffer with a pH value of 9.2-9.8 as a base solvent, and the added antigen is 0.09-0.11 μg / ml NS1 protein; preferably, the coating solution uses a carbonate buffer with a pH value of 9.6 as a base solvent, and the added antigen is 0.1 μg / ml NS1 protein; the NS1 protein is obtained by gene expression of the nucleotide sequence shown in SEQ ID NO.1.
[0019] Preferably, the detection kit further comprises one or more of an antigen-coated plate, an enzyme-labeled monoclonal antibody, a sample diluent, a positive control serum, a negative control serum, a luminescent substrate, a washing solution and a calibrator.
[0020] The present invention utilizes the coated antigen to prepare a microplate kit based on a chemiluminescent immunoassay method, which can perform detection more accurately, more sensitively and more efficiently, and is of great significance for preventing and controlling the infection and epidemic of duck Tembusu virus.
[0021] Preferably, the sample diluent of the present invention is a phosphate buffer containing casein and Tween-20; based on the volume of the phosphate buffer as 100 vol%, the casein content is preferably 0.4-0.6 vol%, more preferably 0.5 vol%; the Tween-20 content is preferably 0.4-0.6 vol%, more preferably 0.5 vol%.
[0022] Preferably, the luminescent substrate of the present invention comprises a luminescent substrate A and a luminescent substrate B; the luminescent substrate A is based on a Tris buffer solution with a pH value of 7.5-8.5 and a concentration of 0.04-0.06 mol / L, and is added with 0.08-0.12 mmol / L of luminol and 0.08-0.12 g / L of hydroxycoumarin; the luminescent substrate B is based on an ammonium acetate solution with a pH value of 5.0-5.5 and a concentration of 0.04-0.06 mol / L, and is added with 0.06-0.08 mmol / L of vitamin C and 2.7-3.3 mmol / L of amino acid oxidase. More preferably, the luminescent substrate A uses Tris buffer with a pH value of 8.0 and a concentration of 0.05 mol / L as the base solvent, and adds 0.1 mmol / L luminol and 0.1 g / L hydroxycoumarin; the luminescent substrate B uses ammonium acetate solution with a pH value of 5.2 and a concentration of 0.05 mol / L as the base solvent, and adds 0.07 mmol / L vitamin C and 3.0 mmol / L amino acid oxidase.
[0023] Preferably, the washing solution of the present invention comprises 0.018-0.022 mol / L of sodium dihydrogen phosphate, 0.07-0.09 mol / L of sodium dihydrogen phosphate, 1.29-1.45 mol / L of sodium chloride and 0.4-0.6 vol% of Tween-20 based on a 10-fold concentration; more preferably, the washing solution comprises 0.02 mol / L of sodium dihydrogen phosphate, 0.08 mol / L of sodium dihydrogen phosphate, 1.37 mol / L of sodium chloride and 0.5 vol% of Tween-20 based on a 10-fold concentration; the pH value of the washing solution is preferably 7.3-7.5, more preferably 7.4 based on a 10-fold concentration.
[0024] In a third aspect, the present invention also provides the use of the detection kit in the detection of duck Tembusu virus for non-disease diagnosis purposes, and the application includes detecting whether vaccine products, blood products or poultry processed products contain duck Tembusu virus.
[0025] Preferably, the application comprises the following steps:
[0026] S1. Mix the sample to be tested and the calibrator with the enzyme-labeled monoclonal antibody respectively, add them to the coated plate, and react;
[0027] S2, washing the coated plate after the reaction in step S1 with a washing solution, adding a luminescent substrate, and detecting the luminescence value using a chemiluminescent immunoassay detection instrument;
[0028] S3, according to the luminescence value obtained in step S3, the antibody dosage in the sample to be tested is obtained by fitting and calculating the calibration curve;
[0029] S4. Determine whether the test sample contains duck Tembusu virus according to the antibody dosage obtained in step S4;
[0030] The determination method in step S4 includes:
[0031] If the antibody dose value is <40, the sample is judged to be antibody negative; if the antibody dose value is ≥40, the sample is judged to be antibody positive.
[0032] The duck Tembusu virus chemiluminescent ELISA antibody detection kit provided by the present invention adopts the competitive reaction principle, NS1 recombinant protein is coated on the coating plate, specific antibodies and enzyme-labeled antibodies (enzyme conjugates) in the sample to be tested competitively bind to the recombinant protein, the antibody dosage value in the sample to be tested is inversely proportional to the luminescent signal value, and the antibody dosage in the sample to be tested can be obtained by calibration curve fitting calculation.
[0033] In a more specific embodiment provided by the present invention, the application includes the following steps: setting a series of 6 calibrators, first adding 60 μL of calibrators 1 to 6 on the serum dilution plate in sequence, and then adding 60 μL of the sample to be tested to each of the remaining wells in sequence, and then adding 60 μL of enzyme conjugate to each of the above wells, shaking and mixing; 100 μL of each well is transferred to the corresponding well of the antigen-coated plate. The antigen-coated plate is reacted at 37°C for 30 minutes; washed with washing solution 5 times, luminescent substrate A and luminescent substrate B are added, reacted at 15-25°C for 5 minutes, and the luminescent value is detected by a chemiluminescent immunoassay detection instrument.
[0034] The present invention prepares a series of calibration products, uses a four-parameter method to draw a calibration product curve, and can directly and quantitatively calculate the antibody dosage value of the sample. Based on this, a detection kit is developed to more accurately and sensitively detect duck Tembusu virus antibodies in duck serum.
[0035] The kit of the present invention reduces the sample pre-treatment process, consumes less time, can detect a large number of samples at the same time, can achieve semi-automation, and has important practical significance for achieving rapid detection of large quantities of samples.
[0036] Beneficial effects:
[0037] The present invention provides a duck Tembusu virus detection kit and application. The antigen protein coated in the kit is NS1 recombinant protein. NS1 protein is the main antigen in the virus infection process and can induce the body to produce high levels of antibodies. The present invention uses NS1 protein as the coating antigen in the duck Tembusu virus detection kit, and utilizes the main production time of NS1 protein (NS1 protein is produced when the virus infects cells) to distinguish antibodies produced by natural infection and inactivated vaccine immunization. At the same time, NS1 protein can be detected in the early stage of duck Tembusu virus infection, indicating that NS1 protein is related to the early infection of the virus, and NS1 protein can be used to accurately detect duck Tembusu virus disease in the early stage of infection. The application of NS1 protein in the chemiluminescent ELISA antibody detection kit provided by the present invention has the advantages of high accuracy, high sensitivity, strong specificity, high detection efficiency, etc., and is of great significance for preventing and controlling the occurrence and prevalence of duck Tembusu disease. DETAILED DESCRIPTION
[0038] The technical solutions provided by the present invention are described in detail below in conjunction with the examples, but they should not be understood as limiting the scope of protection of the present invention. Unless otherwise specified, the experimental methods used in the examples are conventional methods; the materials and reagents used can be obtained from commercial sources.
[0039] Example 1
[0040] The present embodiment provides a duck Tembusu virus chemiluminescent ELISA antibody detection kit, which includes an antigen-coated plate, an enzyme-labeled monoclonal antibody, a serum diluent, a positive control serum, a negative control serum, a luminescent substrate A, a luminescent substrate B, and a 10-fold concentrated washing solution.
[0041] (1) The antigen-coated plate is a white opaque polystyrene 96-well plate, which is coated with the NS1 protein of duck Tembusu disease; the coating process is as follows: add the NS1 protein to a carbonate buffer solution with a pH of 9.6 to make the concentration of the NS1 protein 0.1ug / mL, and add the protein coating solution to the coated plate at a volume of 100uL / well. Coat at 37℃ for 3h; shake off the protein coating solution in the plate, add 150uL / well of 5% BSA-PBST to each well for blocking, and block at 37℃ for 2h; shake off the blocking solution in the plate, dry at 25℃ for 2h, put in a desiccant, seal and package, and store at 2-8℃;
[0042] (2) NS1 protein is a recombinant protein. Based on the gene sequence of duck Tembusu virus NS1 protein published in GenBank, primers for synthesizing NS1 protein gene were designed. The gene sequence cDNA of duck Tembusu virus NS1 protein was used as a template to PCR amplify the NS1 fragment and connect it with the pMD18-T-simple vector to construct a recombinant cloning plasmid, which was transformed into Escherichia coli DH5α. Positive clones were screened by bacterial liquid PCR, double enzyme digestion and gene sequencing. Then, the positive recombinant cloning plasmid and expression vector pPICZαC were double digested with restriction endonucleases to recover the target gene. DNA ligase was used to connect and construct a recombinant expression plasmid, which was transformed into Escherichia coli DH5α. Positive recombinant expression plasmids were screened by bacterial liquid PCR, double enzyme digestion and gene sequencing to construct an expression plasmid. The positive recombinant expression plasmid was linearized with PmeⅠ and transformed into Pichia pastoris X-33 by electroporation. The positive recombinants were screened for induced expression, and the recombinant proteins were identified by SDS-PAGE analysis and Western-blot. The purified recombinant proteins were tested for biological activity using duck Tembusu virus enzyme-linked immunosorbent assay. The protein was used to coat chemiluminescent plates to detect duck Tembusu virus antibody serum and duck Tembusu virus antibody negative serum. The results showed that the expressed NS1 protein had good sensitivity and specificity. The nucleotide sequence of the NS1 protein is shown in SEQ ID NO.1, and the antigen immune effect obtained by the yeast expression system is good. At the same time, the yeast expression system is simpler and more convenient, with low cost, and the secretory expression product is easy to purify. The recombinant NS1 protein can be correctly folded and glycosylated, and has the biological activity that the natural protein should have, which can improve the protein expression efficiency.
[0043] (3) Preparation, purification and identification of monoclonal antibodies: 6-8 week old female SALB / c mice were immunized with purified recombinant protein, and a shock immunization was performed after three immunizations. The spleen cells of the immunized mice were fused with myeloma cells SP2 / 0 and subcloned three times. Positive hybridoma cell lines were screened by indirect ELISA. The cells were expanded and ascites was prepared. The collected ascites was purified and labeled with HRP to obtain enzyme-labeled monoclonal antibodies. The expressed NS1 protein was subjected to SDS-PAGE electrophoresis and then transferred to a nitrocellulose membrane, where it reacted with the enzyme-labeled monoclonal antibody to produce specific protein bands.
[0044] (4) The enzyme conjugate was an enzyme-labeled monoclonal antibody, diluted to a working concentration with 5% BSA-PBST;
[0045] (5) The serum diluent is phosphate buffer containing 5% (v / v) casein and 0.5% (v / v) Tween-20, pH = 7.4.
[0046] (6) Luminescent substrate A contains 0.1 mmol / L luminol and 0.01% hydroxycoumarin by volume; the solvent is 0.05 mol / L Tris buffer at pH = 8.0;
[0047] (7) The luminescent substrate B contains 0.07 mmol / L vitamin C and 3 mmol / L amino acid oxidase, and the solvent is 0.05 mol / L ammonium acetate solution with a pH of 5.2.
[0048] (8) The 10-fold concentrated washing solution is 0.02 mol / L sodium dihydrogen phosphate, 0.08 mol / L sodium dihydrogen phosphate, 1.37 mol / L sodium chloride and 0.5% (v / v) Tween-20, pH = 7.4.
[0049] (9) Calibrators: Calibrator 1 is prepared by diluting the standard negative serum with serum diluent at a ratio of 1:20, and assigning the antibody dose value to 0 NCU / mL; Calibrators 2 to 6 are prepared by diluting the standard positive serum with serum diluent in proportion to the antibody dose value, and diluting them to 10 NCU / mL, 20 NCU / mL, 40 NCU / mL, 100 NCU / mL and 200 NCU / mL, respectively, and sterilely quantitatively packaged and stored at 2-8°C.
[0050] The duck Tembusu virus chemiluminescent ELISA antibody detection kit adopts the principle of competitive reaction. The NS1 recombinant protein is coated on the coating plate. The specific antibody and enzyme-labeled antibody (enzyme conjugate) in the sample to be tested competitively bind to the recombinant protein. The antibody dosage value in the sample to be tested is inversely proportional to the luminescent signal value. The antibody dosage in the sample to be tested can be obtained by fitting and calculating the calibration curve.
[0051] This embodiment also provides a method for detecting using the duck Tembusu virus chemiluminescent ELISA antibody detection kit, and the detection steps are as follows:
[0052] Each experiment sets up 6 wells of series calibration. First, add 60μL of calibration standards 1 to 6 to the serum dilution plate in sequence, and add 60μL of the sample to be tested to the remaining wells in sequence. Then add 60μL of enzyme conjugate to each of the above wells and shake to mix; transfer 100μL from each well to the corresponding well of the antigen-coated plate. React the antigen-coated plate at 37℃ for 30min; wash it 5 times with washing solution, add luminescent substrate A and luminescent substrate B, react at 15-25℃ for 5min, and detect the luminescence value with a chemiluminescent immunoassay detection instrument.
[0053] Example 2
[0054] Establishment of the chemiluminescent ELISA antibody detection kit for duck Tembusu virus:
[0055] The optimal coating concentration and enzyme-labeled monoclonal antibody dilution multiple were determined by the chessboard titration method. The antigen NS1 protein was made into a gradient of 2ug / ml, 1.6ug / ml, 1ug / ml, 0.5ug / ml and 0.1ug / ml, and the enzyme-labeled monoclonal antibody dilution multiple was 1:1000, 1:2000, 1:5000, 1:10000. By detecting the calibrator and drawing the calibrator curve, the coating condition was determined to be 0.1ug / ml coating of the antigen NS1 protein. The enzyme-labeled monoclonal antibody dilution multiple was 1:2000.
[0056] Example 3
[0057] The critical value of the duck Tembusu virus chemiluminescent ELISA antibody detection kit is determined by using the kit of the present invention to detect serum with a known background.
[0058] The kit was used to detect 50 duck Tembusu virus antibody-positive samples and 180 antibody-negative samples, and the antibody dose value of each sample was calculated. The antibody dose value of all serum samples was analyzed using SPSS16.0 software. The ROC curve was constructed using a non-parametric method, and the maximum value of the Youden index was used as the critical point for positive and negative judgment. The sensitivity and specificity of the kit were also determined. Finally, the judgment standard of this kit was set as follows: if the antibody dose value was <40, the sample was judged as antibody-negative; if the antibody dose value was ≥40, the sample was judged as antibody-positive. Under this judgment standard, the sensitivity of the duck Tembusu virus chemiluminescent ELISA antibody detection kit was 95.38% and the specificity was 94.29%, which proved that the kit had high accuracy, good sensitivity and specificity, and had high diagnostic application value.
[0059] Example 4
[0060] Duck Tembusu virus chemiluminescent ELISA antibody detection kit sensitivity and specificity detection:
[0061] The duck Tembusu disease positive serum was diluted with serum diluent in multiple ratios, and the gradients were 1:32, 1:64, 1:128, 1:256, 1:512, and 1:1024, respectively. The diluted samples were directly tested. The duck plague positive serum, duck viral hepatitis positive serum, duck influenza positive serum, duck infectious encephalomyelitis positive serum, and duck plague Riemerella anatipestifer positive serum samples were diluted. Results The duck Tembusu virus chemiluminescent ELISA antibody detection kit of the present invention has good sensitivity, and the sensitivity of the duck Tembusu disease antibody kit can reach 1:512. The duck Tembusu virus chemiluminescent ELISA antibody detection kit of the present invention has good specificity and has no cross reaction with the above-mentioned positive serum samples. Therefore, the kit of the present invention has high sensitivity and strong specificity. The specific results are shown in Table 1.
[0062] Table 1 Sensitivity and specificity results
[0063] Sample name determination Sample name determination Duck Tembusu virus positive serum 1:32 Positive Duck plague positive serum Negative Duck Tembusu virus positive serum 1:64 Positive Duck viral hepatitis positive serum Negative Duck Tembusu virus positive serum 1:128 Positive Duck influenza positive serum Negative Duck Tembusu virus positive serum 1:256 Positive Duck infectious encephalomyelitis positive serum Negative Duck Tembusu virus positive serum 1:512 Positive Positive serum for Riemerella anatipestifer Negative Duck Tembusu virus positive serum 1:1024 Negative / /
[0064] Example 5
[0065] Repeatability test of duck Tembusu virus chemiluminescent ELISA antibody detection kit:
[0066] Five sera with clear background were repeated five times on the same antigen-coated plate, and the intra-batch coefficient of variation (CV) was calculated. At the same time, the five sera with clear background were repeated on three different batches of antigen-coated plates, and the inter-batch coefficient of variation (CV) was calculated. The results showed that both the intra-batch and inter-batch CVs were less than 10%, with good repeatability. The specific results are shown in Table 2.
[0067] Table 2 Repeatability results
[0068]
[0069] Example 6
[0070] Stability test of duck Tembusu virus chemiluminescent ELISA antibody detection kit:
[0071] In order to test the stability and shelf life of the kit, the kit was placed at 2-8°C and taken out at 1, 3, 6, 9, 12 and 15 months for sensitivity and specificity tests. The results showed that at the 15th month, the sensitivity and specificity test results of the kit were normal. Therefore, the kit can be stably stored at 2-8°C for 15 months, and the chemiluminescence kit has good stability.
[0072] Example 7
[0073] Comparison of the test results of duck Tembusu virus chemiluminescent ELISA antibody detection kit and commercial duck Tembusu virus antibody ELISA kit on known duck Tembusu disease antibody-positive and antibody-negative samples:
[0074] The duck Tembusu virus chemiluminescent ELISA antibody detection kit and the commercial duck Tembusu virus antibody ELISA kit (Shanghai Yanyu Biotechnology Co., Ltd., catalog number: YJ622513) were used to detect 50 known antibody positive samples and 50 known antibody negative samples collected, and the results of the chemiluminescent kit detection results were all consistent. The commercial duck Tembusu virus antibody ELISA kit detected 50 positive samples and detected 45 positive samples. The commercial duck Tembusu virus antibody ELISA kit detected 50 negative samples and detected 42 negative samples. The detection rate and compliance rate of the chemiluminescent antibody kit for positive and negative samples were higher than those of the duck Tembusu virus indirect ELISA antibody detection kit. There is an obvious false positive problem in the detection of negative samples by the duck Tembusu virus indirect ELISA antibody detection kit. The specific results are shown in Tables 3 and 4.
[0075] Table 3 Test results of known positive samples
[0076]
[0077]
[0078]
[0079] Table 4 Test results of known negative samples
[0080]
[0081]
[0082]
[0083] The above-mentioned embodiments only express several implementation methods of the present invention, which is convenient for understanding the technical solution of the present invention in detail, but it cannot be understood as limiting the scope of the invention patent protection. It should be pointed out that for ordinary technicians in this field, several modifications and improvements can be made without departing from the concept of the present invention, which all belong to the protection scope of the present invention.
Claims
1. A chemiluminescent ELISA antibody detection kit, characterized in that: Including coating solution, antigen coating plate, enzyme-labeled monoclonal antibody, sample diluent, positive control serum, negative control serum, luminescent substrate, washing solution and calibrator; The coating solution uses a carbonate buffer solution with a pH value of 9.2-9.8 as a base solvent, and the added antigen is 0.09-0.11 μg / ml of NS1 protein; the NS1 protein is obtained by expressing the gene of the nucleotide sequence shown in SEQ ID NO.1 through a yeast expression system, and the yeast expression system is obtained by transforming the PmeI linearized positive recombinant expression plasmid into Pichia pastoris X-33 through electrotransformation; The enzyme-labeled monoclonal antibody is HRP enzyme-labeled monoclonal antibody, and the dilution multiple is 1:2000; The sample diluent is a phosphate buffer containing casein and Tween-20; based on the volume of the phosphate buffer being 100 vol%, the casein content is 0.4-0.6 vol%, and the Tween-20 content is 0.4-0.6 vol%; The luminescent substrate comprises a luminescent substrate A and a luminescent substrate B; the luminescent substrate A is based on a Tris buffer solution with a pH value of 7.5-8.5 and a concentration of 0.04-0.06 mol / L, and is added with 0.08-0.12 mmol / L of luminol and 0.08-0.12 g / L of hydroxycoumarin; the luminescent substrate B is based on an ammonium acetate solution with a pH value of 5.0-5.5 and a concentration of 0.04-0.06 mol / L, and is added with 0.06-0.08 mmol / L of vitamin C and 2.7-3.3 mmol / L of amino acid oxidase; The washing solution, when concentrated 10 times, includes 0.018-0.022 mol / L of sodium dihydrogen phosphate, 0.07-0.09 mol / L of disodium hydrogen phosphate, 1.29-1.45 mol / L of sodium chloride and 0.4-0.6 vol% of Tween-20; the washing solution, when concentrated 10 times, has a pH value of 7.3-7.5; The detection method of the chemiluminescent ELISA antibody detection kit comprises the following steps: S1, mixing the sample to be tested and the calibrator with the enzyme-labeled monoclonal antibody respectively and adding them to the coated plate for reaction; S2, washing the coated plate after the reaction in step S1 with a washing solution, adding a luminescent substrate, and detecting the luminescence value using a chemiluminescent immunoassay detection instrument; S3, according to the luminescence value obtained in step S3, the antibody dosage in the sample to be tested is obtained by fitting and calculating the calibration curve; S4. Determine whether the test sample contains duck Tembusu virus according to the antibody dosage obtained in step S4; The determination method in step S4 includes: If the antibody dose value is <40, the sample is judged to be antibody negative; If the antibody dose value is ≥40, the sample is judged to be antibody positive.
2. The use of the chemiluminescent ELISA antibody detection kit according to claim 1 in the detection of duck Tembusu virus for non-disease diagnosis purposes, characterized in that: The steps include: S1. Mix the sample to be tested and the calibrator with the enzyme-labeled monoclonal antibody respectively, add them to the coated plate, and react; S2, washing the coated plate after the reaction in step S1 with a washing solution, adding a luminescent substrate, and detecting the luminescence value using a chemiluminescent immunoassay detection instrument; S3, according to the luminescence value obtained in step S3, the antibody dosage in the sample to be tested is obtained by fitting and calculating the calibration curve; S4. Determine whether the test sample contains duck Tembusu virus according to the antibody dosage obtained in step S4; The determination method in step S4 includes: If the antibody dose value is <40, the sample is judged to be antibody negative; If the antibody dose value is ≥40, the sample is judged to be antibody positive.
